Is Butylene Glycol an Endocrine Disruptor? An Evidence-Based Answer

If you sort your skincare by what it might be doing to your hormones — and if you’re here, you probably do — butylene glycol is exactly the kind of ingredient that earns a second look. It’s synthetic. It has “glycol” in the name. It shows up on a few “ingredients we avoid” lists that lump it in with genuinely concerning chemicals. So the question is fair, and it deserves a real answer rather than a reassuring shrug: is butylene glycol an endocrine disruptor?

The short version: no — butylene glycol is not classified as an endocrine disruptor by any major safety body, it is permitted without restriction in the European Union (which bans endocrine disruptors from cosmetics outright), and the one legitimate concern people raise about it — trace 1,4-dioxane — does not actually apply to this ingredient. Below is the evidence for each of those claims, with sources you can check yourself.

An endocrine-disrupting chemical (EDC) is a substance that interferes with the body’s hormone systems — mimicking, blocking, or altering hormone signaling. The EDCs that matter most in skincare are well-characterized: certain parabens, phthalates often hidden inside “fragrance,” and UV filters like oxybenzone. These have measurable hormonal activity in published studies. That is the bar. The question for any ingredient is not “does it sound synthetic” but “does it have demonstrated hormonal activity at the concentrations used.”

Butylene glycol does not. It’s a small four-carbon diol (more precisely, 1,3-butanediol) whose job is to hold water and help a formula stay stable and absorb well. It has no estrogenic, anti-androgenic, or thyroid-disrupting activity reported in the toxicology literature. For the full picture of what it is and how it’s made, see What Is Butylene Glycol in Skincare?.

Here is the single most useful fact for anyone screening for hormone safety. Under the EU Cosmetics Regulation (EC) No 1223/2009 — the most precautionary cosmetics framework in the world — substances with endocrine-disrupting properties are prohibited from cosmetic products. [1]

Butylene glycol is not on the EU’s prohibited list (Annex II). It is freely permitted, with no concentration restriction specific to endocrine concern. Think about what that means: a regulatory system that will pull an ingredient the moment credible evidence of hormonal activity emerges has looked at butylene glycol and left it on the shelf. If it were a hormone disruptor, it would be banned there. It isn’t. That’s not Juventude’s opinion — it’s the regulatory record.

This matters to us specifically because Juventude formulates to EU compliance by choice, not because we ship to Europe. The EU standard is our floor.

The Cosmetic Ingredient Review (CIR) Expert Panel — the independent, FDA-and-industry-supported body that assesses cosmetic ingredients — reviewed butylene glycol specifically and concluded it is safe as used in cosmetics. Its assessment covered acute, subchronic, and chronic toxicity studies and found a low order of toxicity; a repeated-insult patch test produced no evidence of skin sensitization. [2]

The Environmental Working Group — an organization known for flagging ingredients aggressively, not generously — lists butylene glycol as a low-hazard ingredient in its Skin Deep database. [3] When even EWG isn’t worried, that tells you something.

This is the concern worth taking seriously, because it’s the one that has a real basis — it’s just been pinned on the wrong ingredient. A handful of “clean beauty” pages claim butylene glycol can be contaminated with 1,4-dioxane, a probable human carcinogen. Here’s the actual chemistry.

1,4-dioxane is a byproduct of ethoxylation — a manufacturing process that adds ethylene oxide to an ingredient. The FDA identifies the at-risk ingredients precisely: those with “PEG,” “Polyethylene glycol,” “Polyoxyethylene,” “-eth-,” or “-oxynol-” in the name. [4] Butylene glycol is none of these. It is not ethoxylated — it’s a simple diol that never goes through that process. So the dioxane pathway that contaminates ingredients like Sodium Laureth Sulfate or PEG-100 Stearate structurally cannot produce dioxane in butylene glycol.

We’ll be straight with you about where this does apply: an ethoxylated ingredient like Polysorbate 20 is the kind of ingredient the dioxane question is actually about. Responsible suppliers vacuum-strip it to remove residual dioxane, and the FDA notes levels have declined significantly over time. [4] That’s the honest version of the story — and it’s the opposite of the ingredient people worry about.

Three things, mostly. First, the word “glycol” sits next to genuinely problematic compounds in people’s minds (it is unrelated to ethylene glycol antifreeze or to glycol ethers of industrial concern). Second, butylene glycol is a mild penetration enhancer — it helps other ingredients absorb — and some lists twist that into “it drives toxins deeper,” which only matters if the rest of your formula contains toxins. Ours doesn’t. Third, ingredient fear travels faster than ingredient science. We’d rather give you the science.